Arcellx (ACLX)

• Market cap: $3.82B
• 1 day: 0.75%
• 5 days: 1.6%
• 1 month: -11.95%
• 3 months: -16.19%
• 6 months: 4.18%
• Year to date: -16.19%
• 1 year: -14.93%
• 5 years: 292.86%
• 10 years: 292.86%
• Sector: Healthcare
• Industry: Biotechnology

About: Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

Employees: 163